GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Enterprise Value

U-Neuron Biomedical (ROCO:6973) Enterprise Value : NT$919.60 Mil (As of Jun. 09, 2024)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, U-Neuron Biomedical's Enterprise Value is NT$919.60 Mil. U-Neuron Biomedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-84.84 Mil. Therefore, U-Neuron Biomedical's EV-to-EBIT ratio for today is -10.84.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, U-Neuron Biomedical's Enterprise Value is NT$919.60 Mil. U-Neuron Biomedical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-77.87 Mil. Therefore, U-Neuron Biomedical's EV-to-EBITDA ratio for today is -11.81.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, U-Neuron Biomedical's Enterprise Value is NT$919.60 Mil. U-Neuron Biomedical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$27.02 Mil. Therefore, U-Neuron Biomedical's EV-to-Revenue ratio for today is 34.03.


U-Neuron Biomedical Enterprise Value Historical Data

The historical data trend for U-Neuron Biomedical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Enterprise Value Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Enterprise Value
- - - 1,306.71

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value - - - - 1,306.71

Competitive Comparison of U-Neuron Biomedical's Enterprise Value

For the Biotechnology subindustry, U-Neuron Biomedical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's Enterprise Value falls into.



U-Neuron Biomedical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

U-Neuron Biomedical's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

U-Neuron Biomedical's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U-Neuron Biomedical  (ROCO:6973) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

U-Neuron Biomedical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=919.601/-84.836
=-10.84

U-Neuron Biomedical's current Enterprise Value is NT$919.60 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-84.84 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

U-Neuron Biomedical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=919.601/-77.873
=-11.81

U-Neuron Biomedical's current Enterprise Value is NT$919.60 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-77.87 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

U-Neuron Biomedical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=919.601/27.023
=34.03

U-Neuron Biomedical's current Enterprise Value is NT$919.60 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$27.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U-Neuron Biomedical Enterprise Value Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines